A Multicenter Study to Evaluate the Effects of a 91-day Oral Contraceptive on Bone Mineral Density in Adolescent Females

Trial ID or NCT#

NCT00924560

Status

not recruiting iconNOT RECRUITING

Purpose

This study is being conducted to compare the effects of a 91-day oral contraceptive (OC) to a 28-day OC regimen on bone mineral density (BMD) in adolescent females.

Official Title

A Multicenter, Open-Label, Randomized, Controlled Study to Compare the Effects on Bone Mineral Density of DR-105 and a 28-Day Cycle Oral Contraceptive Regimen in Healthy, Postmenarchal, Adolescent Females

Eligibility Criteria

Ages Eligible for Study: 12 Years to 18 Years
Sexes Eligible for Study: FEMALE
Accepts Healthy Volunteers: Yes
Inclusion Criteria:
  1. * Healthy postmenarchal adolescent female 12-18 years old, non-pregnant, nonlactating* Regular spontaneous menstrual cycles* Body mass index (BMI): 18 kg/m² to \<30 kg/m², weight \< 200 lbs* Others as dictated by the Food and Drug Administration (FDA)-approved protocol
Exclusion Criteria:
  1. * Any contraindication to the use of oral contraceptives* History of previous clinically significant adverse event while taking hormonal contraceptives* Use of any medication which could significantly interfere with study assessments* Others as dictated by FDA-approved protocol
View All Criteria
Show Less

Investigator(s)

Neville H. Golden M.D.

Contact us to find out if this trial is right for you.

Contact

Kelsey Lynd
6507211237

View on ClinicalTrials.gov